BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Prognosis
41 results:

  • 1. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
    Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
    Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
    Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ZNF384-Related Fusion Genes in Acute Lymphoblastic leukemia.
    Zhu L; Bai W; Cheng Q; Fang J
    Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/crebbp fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinical Study on the Relationship between Gene Mutation Profile and prognosis in Pediatric Acute Lymphocyte leukemia].
    Chen Y; Qi SS; Ding LL; DU Y; Song N; Wang Z; Yang L; Sun M; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):17-24. PubMed ID: 36765471
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
    Zhang T; Liu H; Gao F; Gong W; Cui Y; He J; Li L; Qiu L; Qian Z; Zhou S; Meng B; Ren X; Zhang H; Wang X
    Front Immunol; 2022; 13():922471. PubMed ID: 35734168
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advances in the Treatment of Hairy Cell leukemia Variant.
    Tran J; Gaulin C; Tallman MS
    Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic.
    Chen Y; Zheng Y; Hong Y; Wen J; Li J; Huang Y; Chen Y; Zheng X; Yang T; Xu Y; Zheng J; Hu J
    J Leukoc Biol; 2022 Sep; 112(3):513-522. PubMed ID: 35172382
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
    Zhang S; Zhang T; Liu H; Zhao J; Zhou H; Su X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; He J; Wang X; Zhang H
    Br J Haematol; 2022 Feb; 196(3):617-628. PubMed ID: 34664256
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Acute leukemia of infants and neonates].
    Eguchi M
    Rinsho Ketsueki; 2021; 62(8):1308-1318. PubMed ID: 34497221
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
    Kayser S; Hills RK; Langova R; Kramer M; Guijarro F; Sustkova Z; Estey EH; Shaw CM; Ráčil Z; Mayer J; Zak P; Baer MR; Brunner AM; Szotkowski T; Cetkovsky P; Grimwade D; Walter RB; Burnett AK; Ho AD; Ehninger G; Müller-Tidow C; Platzbecker U; Thiede C; Röllig C; Schulz A; Warsow G; Brors B; Esteve J; Russell NH; Schlenk RF; Levis MJ
    Br J Haematol; 2021 Mar; 192(5):832-842. PubMed ID: 33529373
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Gene Mutation in Acute Lymphoblastic leukemia by DNA Sequencing].
    Zheng RY; Wang SJ; Wang C; Li T; Liao LX; Li ML; Chen SM; Guo R; Wang WQ; Zhang Y; Fan Y; Wan DM; Liu YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1791-1795. PubMed ID: 33283700
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Downregulating crebbp inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
    Gao C; Liu SG; Lu WT; Yue ZX; Zhao XX; Xing TY; Chen ZP; Zheng HY; Li ZG
    Mol Med Rep; 2020 Oct; 22(4):2905-2915. PubMed ID: 32945392
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. m7FLIPI and targeted sequencing in high-risk follicular lymphoma.
    Sorigue M; Oliveira A; Mercadal S; Tapia G; Climent F; Perez-Roca L; Lorences I; Domingo-Domenech E; Cabezon M; Navarro JT; Gonzalez-Barca E; Zamora L; Ribera JM; Sureda A; Armengol MP; Sancho JM
    Hematol Oncol; 2019 Dec; 37(5):564-568. PubMed ID: 31475375
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterization of Copy Number Variations in Oral Cavity Squamous Cell Carcinoma Reveals a Novel Role for MLLT3 in Cell Invasiveness.
    Wang CI; Kao HK; Chen TW; Huang Y; Cheng HW; Yi JS; Hung SY; Wu CS; Lee YS; Chang KP
    Oncologist; 2019 Dec; 24(12):e1388-e1400. PubMed ID: 31273053
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway.
    Chae HD; Cox N; Capolicchio S; Lee JW; Horikoshi N; Kam S; Ng AA; Edwards J; Butler TL; Chan J; Lee Y; Potter G; Capece MC; Liu CW; Wakatsuki S; Smith M; Sakamoto KM
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2307-2315. PubMed ID: 31253529
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification and Characterization of Novel Fusion Genes with Potential Clinical Applications in Mexican Children with Acute Lymphoblastic leukemia.
    Mata-Rocha M; Rangel-López A; Jiménez-Hernández E; Morales-Castillo BA; González-Torres C; Gaytan-Cervantes J; Álvarez-Olmos E; Núñez-Enríquez JC; Fajardo-Gutiérrez A; Martín-Trejo JA; Solís-Labastida KA; Medina-Sansón A; Flores-Lujano J; Sepúlveda-Robles OA; Peñaloza-González JG; Espinoza-Hernández LE; Núñez-Villegas NN; Espinosa-Elizondo RM; Cortés-Herrera B; Torres-Nava JR; Flores-Villegas LV; Merino-Pasaye LE; Bekker-Méndez VC; Velázquez-Aviña MM; Pérez-Saldívar ML; Bautista-Martínez BA; Amador-Sánchez R; González-Avila AI; Jiménez-Morales S; Duarte-Rodríguez DA; Santillán-Juárez JD; García-Velázquez AJ; Rosas-Vargas H; Mejía-Aranguré JM
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096545
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing.
    Li Y; Lv X; Ge X; Yuan D; Ding M; Zhen C; Zhao W; Liu X; Wang X; Xu H; Li Y; Wang X
    Mol Med Rep; 2019 May; 19(5):4147-4158. PubMed ID: 30942411
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Role of MSC-derived galectin 3 in the AML microenvironment.
    Ruvolo PP; Ruvolo VR; Burks JK; Qiu Y; Wang RY; Shpall EJ; Mirandola L; Hail N; Zeng Z; McQueen T; Daver N; Post SM; Chiriva-Internati M; Kornblau SM; Andreeff M
    Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(7):959-969. PubMed ID: 29655803
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The incidence and distribution characteristics of MLL rearrangements in Chinese acute myeloid leukemia patients by multiplex nested RT-PCR.
    Yang H; Cao T; Gao L; Wang L; Zhu C; Xu Y; Jing Y; Zhu H; Lv N; Yu L
    Technol Health Care; 2017 Jul; 25(S1):259. PubMed ID: 28582914
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.